Turning Point Therapeutics
Why Robinhood?
You can watch TPTX and buy or sell other stocks, ETFs, and their options commission-free!About TPTX
Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.
TPTX Key Statistics
Stock Snapshot
With a market cap of 3.78B, Turning Point Therapeutics(TPTX) trades at $76.01. The stock has a price-to-earnings ratio of -11.01.
On 2026-07-27, Turning Point Therapeutics(TPTX) stock opened at —, reached a high of —, and a low of —.
Turning Point Therapeutics(TPTX) shares are trading with a volume of 0, against a daily average of 1.17M.
In the last year, Turning Point Therapeutics(TPTX) shares hit a 52-week high of $82.20 and a 52-week low of $23.77.
In the last year, Turning Point Therapeutics(TPTX) shares hit a 52-week high of $82.20 and a 52-week low of $23.77.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.